News

Funded by a contract with the NCI, HemoShear is developing a series of tumor models that recreate a wide variety of cancers for discovery of new drugs. Using

Join Bürkert industry experts and Business Review Webinars, on 25 November to learn more about valuable insights to help your business. The first of a series of webinars

The death toll has reached 3,439 in the worst Ebola-hit nations Guinea, Liberia, and Sierra Leone. The two-year regional financial impact could reach around $32.6bn by the end

The latest deal follows similar third-party deal already established with Nitto Medic in Japan for the distribution of AdenoPlus. The company has also established similar deals in Switzerland,

VELCADE is the first treatment in the United States to be approved for use in previously untreated patients with MCL. This approval extends the utility of VELCADE beyond

The latest partnership is a sales and distribution arrangement, which would allow Cipla Medpro to exclusively promote Teva’s broad pharmaceutical product portfolio in South Africa. Cipla Medpro chief

Under the terms of agreement, GSK will buy 25% stake in Aspen Japan, while the remaining 75% stake would be held by Aspen. AGI said in a statement:

The companies, along with 12 other global drug manufacturers have received letters from the US House Committee on Oversight and Government Reform Ranking Member Elijah Cummings and Senator

Striverdi Respimat has been prescribed as a once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema The